Crosspoint Capital Strategies’s iShares US Medical Devices ETF IHI Stock Holding History

Crosspoint Capital Strategies’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-492	Closed	-$19K	–	32
2018 Q3	$19K	Sell	492 -72	-13%	-$2.56K	0.03%	37
2018 Q2	$19K	Buy	+564	New	+$18.4K	0.04%	45
2017 Q3	–	Sell	-108	Closed	-$3K	–	137
2017 Q2	$3K	Buy	+108	New	+$2.86K	﹤0.01%	119
2016 Q4	–	Sell	-102	Closed	-$2K	–	149
2016 Q3	$2K	Hold	102	–	–	﹤0.01%	109
2016 Q2	$2K	Hold	102	–	–	﹤0.01%	115
2016 Q1	$2K	Sell	102 -1,968	-95%	-$38.2K	﹤0.01%	115
2015 Q4	$39K	Buy	+2,070	New	+$41.4K	0.01%	479
2015 Q2	–	Sell	-90	Closed	-$2K	–	630
2015 Q1	$2K	Sell	90 -1,950	-96%	-$38.1K	﹤0.01%	493
2014 Q4	$38K	Hold	2,040	–	–	0.01%	376
2014 Q3	$34K	Hold	2,040	–	–	0.03%	257
2014 Q2	$35K	Hold	2,040	–	–	0.01%	274
2014 Q1	$34K	Hold	2,040	–	–	0.01%	299
2013 Q4	$34K	Buy	+2,040	New	+$30.4K	0.01%	294

Other funds holding IHI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

DCM

Discovery Capital Management South Norwalk, Connecticut $2.41B AUM 286.33% 1-Year Est. Return

Crosspoint Capital Strategies's IHI Position: Q4 2018 in Review

Crosspoint Capital Strategies sold out of iShares US Medical Devices ETF (IHI) in Q4 2018, closing a stake of 492 shares — an estimated $19K sold.

Crosspoint Capital Strategies first reported a position in IHI in Q4 2013 and held it in 13 quarters. The position peaked at $39K in Q4 2015. 233 funds tracked by Wall St. Rank hold IHI as of Q4 2018.

Crosspoint Capital Strategies reported no remaining iShares US Medical Devices ETF position as of Q4 2018 after selling out during the quarter.
Crosspoint Capital Strategies sold 492 iShares US Medical Devices ETF shares in Q4 2018, an estimated $19K.
Crosspoint Capital Strategies first reported a position in iShares US Medical Devices ETF in Q4 2013 and held it in 13 quarters.
Crosspoint Capital Strategies's iShares US Medical Devices ETF position peaked at $39K in Q4 2015.
233 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q4 2018.

Based on Crosspoint Capital Strategies's 13F filing for Q4 2018, filed 13 Feb 2019.